Purpose

The overall objective of this study is to determine whether a positional maneuver (e.g., prone positioning) decreases the need for escalation of respiratory-related care in patients with coronavirus (COVID-19) pneumonia.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years - COVID-19 positive by nasopharyngeal swab or serostatus - Use of supplemental oxygen OR respiratory rate ≥ 20

Exclusion Criteria

  • BMI ≥ 45 kg/m2 - Pregnancy - Chest tube placement - Hemodynamic instability with mean arterial pressure < 60 mmHg - Thoracic or abdominal wounds - Chest wall deformities - Vertebral column deformities that would preclude prone positioning - Facial trauma or surgery in the last 30 days - Established diagnosis of interstitial lung disease - Prior single or double lung transplant - Surgery for spine, femur, or pelvis in the last 3 months - Thoracic or cardiac surgery in the last 30 days - Pacemaker placement last 7 days

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
No Intervention
Control - Usual Care
Usual Care
Experimental
Intervention - Prone Positioning
Prone Positioning
  • Other: Prone Positioning
    Prone Positioning

Recruiting Locations

More Details

NCT ID
NCT04517123
Status
Completed
Sponsor
Johns Hopkins University

Detailed Description

As the initial outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19) has spread beyond Wuhan, China it has become a pandemic affecting over 178 countries. Of patients admitted to the ICU, upwards of 85% developed the acute respiratory distress syndrome (ARDS) and most if not all required mechanical ventilation. The beneficial effects of prone positioning for ARDS have been well described. Coupling the reported benefits of prone positioning in COVID-19 associated ARDS patients with the known beneficial effects of early prone-positioning in the treatment of ARDS, it is not surprising that many hospital systems are advocating prone positioning for treatment of ARDS in patients with COVID-19. However, as the pandemic continues to progress in the United States and the number of new cases grows as new clusters emerge, the possibility of 'rationing' ventilators becomes more real. Therefore, therapies that prevent the need for mechanical ventilation are desperately needed. Given the distinct benefit that patients with COVID-19 have with prone positioning, the overarching hypothesis of this trial is that patients with high risk for respiratory failure may also benefit from prone positioning.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.